Skip to main content
. 2011 Feb 15;104(4):605–612. doi: 10.1038/bjc.2011.17

Table 2. Treatment response (intention-to-treat analysis, n=49).

Response Gallbladder cancer (n=10) Intrahepatic CCC (n=30) Extrahepatic CCC (n=9) All patients (n=49)
CR
PR 4 (40.0%) 7 (23.3%) 1 (11.1%) 12 (24.5%)
SD 4 (40.0%) 9 (30.0%) 4 (44.4%) 17 (34.7%)
PD 12 (40.0%) 4 (44.4%) 16 (32.7%)
NEa 2 (20.0%) 2 (6.7%) 4 (8.2%)

Abbreviations: CR=complete response; PR=partial response; SD=stable disease; PD=progressive disease; NE=not evaluable; CCC=cholangiocellular carcinoma.

a

Four patients were lost to follow-up.